Takeda Pharmaceutical (TAK) Accumulated Expenses (2018 - 2019)

Takeda Pharmaceutical has reported Accumulated Expenses for 2 years, with the latest figure at $1.6 billion in Q4 2019.

• On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $1.6 billion in Q4 2019; TTM through Nov 2019 was $1.6 billion, a N/A change from a year earlier, with the FY2019 full-year figure at $1.4 billion, up 119.18% from the prior year.
• Accumulated Expenses was $1.6 billion for Q4 2019 at Takeda Pharmaceutical, down from $1.6 billion in the prior quarter.
• The five-year high for Accumulated Expenses was $1.6 billion in Q3 2019, with the low at $624.5 million in Q1 2018.